Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2017

Open Access 01-12-2017 | Research

Impact of 6 months of treatment with intragastric balloon on body fat and quality of life in obese individuals with metabolic syndrome

Authors: Erika Paniago Guedes, Eduardo Madeira, Thiago Thomaz Mafort, Miguel Madeira, Rodrigo Oliveira Moreira, Laura Maria Carvalho de Mendonça, Amélio Fernando de Godoy-Matos, Agnaldo José Lopes, Maria Lucia Fleiuss Farias

Published in: Health and Quality of Life Outcomes | Issue 1/2017

Login to get access

Abstract

Background

Obesity is a worldwide public health issue with a negative impact on quality of life. Different weight loss interventions have demonstrated improvements in quality of life. The aim of this study was to investigate the effect of 6 months of treatment with an intragastric balloon (IGB) on health-related quality of life (HRQOL) and its relation to changes in body fat in obese individuals with metabolic syndrome (MS).

Methods

Fifty obese patients with MS aged 18–50 were selected for treatment with IGB for 6 months. Body fat was assessed with anthropometric measures and dual-energy X-ray absorptiometry (DXA) at baseline and after removal of the IGB. HRQOL was evaluated with the short form of the World Health Organization Quality of Life (WHOQOL-BREF) at baseline and soon after removal of the IGB.

Results

Thirty-nine patients completed the study. After 6 months, there was a significant improvement in quality of life (p = 0.0009) and health (p < 0.0001) perceptions, and in the Physical (p = 0.001), Psychological (p = 0.031), and Environmental domains (p = 0.0071). Anthropometric measures and total fat determined by DXA were directly and significantly related to an improvement in general aspects of quality of life. The decrease in the percentage of total fat was the parameter that better correlated with improvements in quality of life perception after regression (p = 0.032).

Conclusions

In obese individuals with MS, weight loss parameters were associated with short-term improvements in HRQOL after 6 months of treatment with IGB. However, only total fat was independently related to HRQOL perception.

Trial registration

ClinicalTrials.gov NCT01598233.
Literature
1.
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384:766–81.CrossRefPubMedPubMedCentral
2.
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.CrossRefPubMedPubMedCentral
3.
Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Maneg Care. 2016;22(7 Suppl):s176–85.
4.
Global BMI Mortality Collaboration. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–86.CrossRefPubMed
5.
Kritchevsky SB, Beavers KM, Miller ME, Shea MK, Houston DK, Kitzman DW, Nicklas BJ. Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS One. 2015;10(3):e0121993.CrossRefPubMedPubMedCentral
6.
Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes. 1985;35:990–8.CrossRef
7.
Chen TH, Li L, Kochen MM. A systematic review: how to choose appropriate health-related quality of life (HRQOL) measures in routine general practice? J Zhejiang Univ Sci B. 2005;6(9):936–40.CrossRefPubMedPubMedCentral
8.
Oreopoulos A, Padwal R, McAlister FA, Ezekowitz J, Sharma AM, Kalantar-Zadeh K, et al. Association between obesity and health-related quality of life in patients with coronary artery disease. Int J Obes. 2010;34:1434–41.CrossRef
9.
10.
Pan A, Kawachi I, Luo N, Manson JE, Willett WC, FB H, et al. Changes in body weight and health-related quality of life: 2 cohorts of US women. Am J Epidemiol. 2014;180(3):254–62.CrossRefPubMedPubMedCentral
11.
Slagter SN, Van Vliet-Ostaptchouk JV, van Beek AP, Keers JC, Lutgers HL, van der Klauw MM, et al. health-related quality of life in relation to obesity grade, type 2 diabetes, metabolic syndrome and inflammation. PLoS One. 2015;10:e0140599.CrossRefPubMedPubMedCentral
12.
Ul-Haq Z, Mackay DF, Fenwick E, et al. Meta-analysis of the association between body mass index and health-related quality of life among adults, assessed by the SF-36. Obesity (Silver Spring). 2013;21(3):E322–7.CrossRef
13.
Søltoft F, Hammer M, Kragh N. The association of body mass index and health-related quality of life in the general population: data from the 2003 health survey of England. Qual Life Res. 2009;18:1293–9.CrossRefPubMedPubMedCentral
14.
Lee DW, Kim S, Cho DY. Obesity-related quality of life and distorted self-body image in adults. Appl Res Qual Life. 2012;8:87–100.CrossRef
15.
Taylor VH, Forhan M, Vigod SN, McIntyre RS, Morrison KM. The impact of obesity on quality of life. Best Pract Res Clin Endocrinol Metab. 2013;27:139–46.CrossRefPubMed
16.
Williamson DA, Rejeski J, Lang W, Van Dorsten B, Fabricatore AN, Toledo K, Look AHEAD. Research group. Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med. 2009;169:163–71.CrossRefPubMedPubMedCentral
17.
Rubin RR, Wadden TA, Bahnson JL, Blackburn GL, Brancati FL, et al. Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the look AHEAD trial. Diabetes Care. 2014;37(6):1544–53.CrossRefPubMed
18.
Bischoff SC, Damms-Machado A, Betz C, Herpertz S, Legenbauer T, Löw T, et al. Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life--a prospective study. Int J Obes. 2012;36(4):614–24.CrossRef
19.
Samsa GP, Kolotkin RL, Williams GR, Nguyen MH, Mendel CM. Effect of moderate weight loss on health-related quality of life: an analysis of combined data from 4 randomized trials of sibutramine vs placebo. Am J Manag Care. 2001;7(9):875–83.PubMed
20.
Biter LU, Ralph PM, Gadiot RPM, Grotenhuis BA, Dunkelgrün M, van Mil SR, et al. The sleeve bypass trial: a multicentre randomized controlled trial comparing the long term outcome of laparoscopic sleeve gastrectomy and gastric bypass for morbid obesity in terms of excess BMI loss percentage and quality of life. BMC Obesity. 2015;2:30.CrossRefPubMedPubMedCentral
21.
Faulconbridge LF, Wadden TA, Thomas JG, Jones-Corneille LR, Sarwer DB, Fabricatore AN. Changes in depression and quality of life in obese individuals with binge eating disorder: bariatric surgery vs. Lifestyle modification Surg Obes Rel Dis. 2013;9(5):790–6.CrossRef
22.
Alcaraz García AM, Ferrer Márquez M, Parrón Carreño T. Quality of life in obese patients and change after bariatric surgery medium and long term. Nutr Hosp. 2015;31(5):2033–46.PubMed
23.
Rutten SJ, de Goederen-van d, Meij S, Pierik RG, Mathus-Vliegen EM. Changes in quality of life after balloon treatment followed by gastric banding in severely obese patients – the use of two different quality of life questionnaires. Obes Surg. 2009;19(8):1124–31.CrossRefPubMed
24.
Driscoll S, Gregory DM, Fardy JM, Twells LK. Long-term health related quality of life in bariatric surgery patients: a systematic review and meta-analysis. Obesity. 2016;24:60–70.CrossRefPubMed
25.
Castro ML, Morales MJ, Del Campo V, Pineda JR, Pena E, Sierra JM, et al. Efficacy, safety and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study. Obes Surg. 2010;20:1642–6.CrossRefPubMed
26.
Mui WL, Ng EK, Tsung BY, Lam CH, Yung MY. Impact on obesity-related illnesses and quality of life following intragastric balloon. Obes Surg. 2010;20(8):1128–32.CrossRefPubMed
27.
Nikolic M, Mirosevic G, Ljubicic N, Boban M, Supanc V, Nikolic BP, Zjacic-Rotkvic V, Bekavac-Beslin M, Gacina P. Obesity treatment using Bioenterics intragastric balloon (BIGB) - preliminary Croatian results. Obes Surg. 2011;21(8):1305–10.CrossRefPubMed
28.
29.
Guedes EP, Madeira E, Mafort TT, Madeira M, Moreira RO, Mendonça MC, et al. Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome. Diabetol Metabolic Syndr. 2013;5:82.CrossRef
30.
Fleck MPA, Louzada S, Xavier M, Chamovich E, Vieira G, Santos L, Pinzon V. Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida “WHOQOL-BREF”. Rev Saúde Pública. 2000;34(2):178–83.CrossRefPubMed
31.
The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28(3):551–8.CrossRef
32.
Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. Reviewers of the AACE/ACE obesity clinical practice guidelines. American Association of Clinical Endocrinologists and American College of endocrinology. Clinical practice guidelines for comprehensive medical care of patients witn obesity. Executive summary. Endocr Pract. 2016;22(7):842–84.CrossRefPubMed
33.
Jia H, Lubetkin EI. The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health (Oxf). 2005;27:156–64.CrossRef
34.
CH W, Kuo HC, Chang CS, Yu C. What extent of weight loss can benefit the health-related quality of life in motivated obese Chinese? Asia Pac J Clin Nutr. 2009;18(3):423–32.
35.
Fuller NR, Pearson S, Lau NS, Wlodarczyk J, Halstead MB, Tee HP, et al. an intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study. Obesity (Silver Spring). 2013;21(8):1561–70.CrossRef
36.
Colwell HH, Mathias SD, Pasta DJ, Henning JM, Steege JFA. Health-related quality-of-life instrument for symptomatic patients with endometriosis: a validation study. Am J Obstet Gynecol. 1988;179(1):47–55.CrossRef
37.
Guedes EP, Madeira E, Mafort TT, Madeira M, Moreira RO, Mendonça LMC, et al. Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome. Diabetol Metab Syndr. 2016; 19;8:81. doi:10.​1186/​s13098-016-0197-6.
Metadata
Title
Impact of 6 months of treatment with intragastric balloon on body fat and quality of life in obese individuals with metabolic syndrome
Authors
Erika Paniago Guedes
Eduardo Madeira
Thiago Thomaz Mafort
Miguel Madeira
Rodrigo Oliveira Moreira
Laura Maria Carvalho de Mendonça
Amélio Fernando de Godoy-Matos
Agnaldo José Lopes
Maria Lucia Fleiuss Farias
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2017
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0790-x

Other articles of this Issue 1/2017

Health and Quality of Life Outcomes 1/2017 Go to the issue

Research

Body image in head and neck cancer patients treated with radiotherapy: the impact of surgical procedures

Research

Validation and reliability of the translated Malay version of the psychosocial impact of dental aesthetics questionnaire for adolescents

Research

“Fibromyalgia and quality of life: mapping the revised fibromyalgia impact questionnaire to the preference-based instruments”

Short report

Depressive symptoms following natural disaster in Korea: psychometric properties of the Center for Epidemiologic Studies Depression Scale

Research

Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module

Research

The impact of resilience on psychological outcomes in women with threatened premature labor and spouses: a cross-sectional study in Southwest China